Infect Control Hosp Epidemiol

• 

  Publication Venue For

  • Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group..  42:1464-1472. 2021
  • The impact of coronavirus disease 2019 (COVID-19) response on hospital infection prevention programs and practices in the southeastern United States..  1-4. 2021
  • Preparing nursing homes for a second wave of coronavirus disease 2019 (COVID-19)..  42:1251-1254. 2021
  • Challenges in hospital-acquired coronavirus disease 2019 (COVID-19) surveillance and attribution of infection source..  1-4. 2021
  • Risk of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) acquisition during ambulance transport: A retrospective propensity-score-matched cohort analysis..  1-6. 2021
  • The impact of patient-reported penicillin or cephalosporin allergy on surgical site infections..  1-5. 2021
  • In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restriction..  1-8. 2021
  • Are we forgetting the "universal" in universal masking? Current challenges and future solutions..  42:784-785. 2021
  • Inappropriate outpatient antibiotic use in children insured by Kentucky Medicaid..  1-7. 2021
  • Assessing severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preparedness in US community hospitals: A forgotten entity..  42:600-603. 2021
  • Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship..  42:519-522. 2021
  • Sustained reduction in catheter-associated urinary tract infections using multi-faceted strategies led by champions: A quality improvement initiative..  1-5. 2021
  • Impact of preoperative chlorhexidine gluconate (CHG) application methods on preoperative CHG skin concentration..  42:464-466. 2021
  • Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction..  42:467-470. 2021
  • VanA rectal swab screening as a predictor of subsequent vancomycin-resistant enterococcal bloodstream infection in critically ill adults..  42:411-416. 2021
  • Burden of healthcare-associated infections among hospitalized children within community hospitals participating in an infection control network..  1-3. 2021
  • Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology..  1-11. 2021
  • Medical transport-associated infection: Review and commentary making a case for its legitimacy..  1-7. 2020
  • Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve..  41:1466-1467. 2020
  • Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system..  41:1351-1353. 2020
  • SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Staphylococcus aureus disease prevention..  41:1251-1257. 2020
  • Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic..  41:1127-1135. 2020
  • Efficacy of UV-C disinfection in hyperbaric chambers..  41:1080-1083. 2020
  • Universal masking in hospitals in the COVID-19 era: Is it time to consider shielding?.  41:1066-1067. 2020
  • Legal implications of antibiotic stewardship programs..  41:757-764. 2020
  • Postdischarge antibiotic use for prophylaxis following spinal fusion..  41:789-798. 2020
  • Reply to Eric Schlote regarding "Evaluation of dilute hydrogen peroxide technology for continuous room decontamination of multidrug-resistant organisms"..  41:738. 2020
  • An evaluation of metrics for assessing catheter-associated urinary tract infections (CAUTIs): A statewide comparison..  41:481-483. 2020
  • Comparative evaluation of the microbicidal activity of low-temperature sterilization technologies to steam sterilization..  41:391-395. 2020
  • Impact of molecular testing on reported Clostridoides difficile infection rates..  41:306-312. 2020
  • Shifting focus toward healthcare-associated bloodstream infections: The need for neonatal intensive care unit-specific NHSN definitions..  41:181-186. 2020
  • Evaluation of dilute hydrogen peroxide technology for continuous room decontamination of multidrug-resistant organisms..  40:1438-1439. 2019
  • Impacts of silver-coated antimicrobial screen covers on the cell-phone microbiome of resident physicians..  40:1427-1429. 2019
  • Research needs in antibiotic stewardship..  40:1334-1343. 2019
  • Antimicrobial activity of a continuously active disinfectant against healthcare pathogens..  40:1284-1286. 2019
  • Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals..  40:1297-1300. 2019
  • Serious superficial incisional surgical site infections (SSISSIs): A proposed surveillance definition..  40:1258-1259. 2019
  • Shifting surgical site infection denominators and implications for National Health Safety Network reporting..  40:1316-1317. 2019
  • Total duration of antimicrobial therapy resulting from inpatient hospitalization..  40:847-854. 2019
  • Diagnosis of urinary tract infections: need for a reflective rather than reflexive approach..  40:834-835. 2019
  • Antibiotic-resistant bacteria on personal devices in hospital intensive care units: Molecular approaches to quantifying and describing changes in the bacterial community of personal mobile devices..  40:717-720. 2019
  • The evolution of catheter-associated urinary tract infection (CAUTI): Is it time for more inclusive metrics?.  40:681-685. 2019
  • Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric..  40:536-540. 2019
  • Route of administration for antibiotics with high oral bioavailability..  40:248-249. 2019
  • A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients-the TransFER study..  40:47-52. 2019
  • Mycobacterium avium pseudo-outbreak associated with an outpatient bronchoscopy clinic: Lessons for reprocessing..  40:106-108. 2019
  • Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016..  39:1487-1490. 2018
  • Water as a source for colonization and infection with multidrug-resistant pathogens: Focus on sinks..  39:1463-1466. 2018
  • Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU..  39:1334-1339. 2018
  • Antimicrobial activity of a continuous visible light disinfection system..  39:1250-1253. 2018
  • Hospital epidemiologists and the art of salesmanship..  39:1269-1270. 2018
  • Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection..  39:1118-1121. 2018
  • Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure..  39:994-996. 2018
  • Association of an Active Surveillance and Decolonization Program on Incidence of Clinical Cultures Growing Staphylococcus aureus in the Neonatal Intensive Care Unit..  39:882-884. 2018
  • Do Periarticular Joint Infections Present an Increase in Infection Risk?.  39:890-891. 2018
  • The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center..  39:878-880. 2018
  • Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals..  39:718-722. 2018
  • Ventilator Bundle Compliance and Risk of Ventilator-Associated Events..  39:637-643. 2018
  • Denominator Matters in Estimating Antimicrobial Use: A Comparison of Days Present and Patient Days..  39:612-615. 2018
  • Antimicrobial Stewardship and Infection Prevention-Leveraging the Synergy: A Position Paper Update..  39:467-472. 2018
  • Hospital-Onset MRSA Bacteremia Rates Are Significantly Correlated With Sociodemographic Factors: A Step Toward Risk Adjustment..  39:479-481. 2018
  • Medically Attended Catheter Complications Are Common in Patients With Outpatient Central Venous Catheters..  39:439-444. 2018
  • To Be a CLABSI or Not to Be a CLABSI-That is the Question: The Epidemiology of BSI in a Large ECMO Population..  39:362-365. 2018
  • Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices..  39:157-163. 2018
  • Multistate Outbreak of an Emerging Burkholderia cepacia Complex Strain Associated With Contaminated Oral Liquid Docusate Sodium..  39:237-239. 2018
  • Self-monitoring by Environmental Services May Not Accurately Measure Thoroughness of Hospital Room Cleaning..  38:1371-1373. 2017
  • The Antimicrobial Scrub Contamination and Transmission (ASCOT) Trial: A Three-Arm, Blinded, Randomized Controlled Trial With Crossover Design to Determine the Efficacy of Antimicrobial-Impregnated Scrubs in Preventing Healthcare Provider Contamination..  38:1147-1154. 2017
  • The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment Methodology..  38:1019-1024. 2017
  • Is There a Correlation Between Infection Control Performance and Other Hospital Quality Measures?.  38:736-739. 2017
  • Using Clinical Scenarios to Understand Preventability of Clostridium difficile Infections by Inpatient Antibiotic Stewardship Programs..  38:747-749. 2017
  • Impact of Changes to the National Healthcare Safety Network (NHSN) Definition on Catheter-Associated Urinary Tract Infection (CAUTI) Rates in Intensive Care Units at an Academic Medical Center..  38:621-623. 2017
  • Paramyxovirus Outbreak in a Long-Term Care Facility: The Challenges of Implementing Infection Control Practices in a Congregate Setting..  38:399-404. 2017
  • Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?.  38:449-454. 2017
  • Interrater Reliability of Surveillance for Ventilator-Associated Events and Pneumonia..  38:172-178. 2017
  • Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals..  38:31-38. 2017
  • Status of the Prevention of Multidrug-Resistant Organisms in International Settings: A Survey of the Society for Healthcare Epidemiology of America Research Network..  38:53-60. 2017
  • Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics..  37:1395-1400. 2016
  • Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Mathematical Modeling..  37:1265-1271. 2016
  • Assessment of Self-Contamination During Removal of Personal Protective Equipment for Ebola Patient Care..  37:1156-1161. 2016
  • A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units..  37:791-797. 2016
  • Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship..  37:627-628. 2016
  • Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Randomized Controlled Trials..  37:629-634. 2016
  • Epidemiology of Surgical Site Infection in a Community Hospital Network..  37:519-526. 2016
  • Surgical Team Stability and Risk of Sharps-Related Blood and Body Fluid Exposures During Surgical Procedures..  37:512-518. 2016
  • Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae..  37:281-288. 2016
  • Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States..  37:49-54. 2016
  • Surgical Procedure Characteristics and Risk of Sharps-Related Blood and Body Fluid Exposure..  37:80-87. 2016
  • Short Operative Duration and Surgical Site Infection Risk in Hip and Knee Arthroplasty Procedures..  36:1431-1436. 2015
  • Seasonal Variation of Common Surgical Site Infections: Does Season Matter?.  36:1011-1016. 2015
  • Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae..  36:942-948. 2015
  • Lessons learned from hospital Ebola preparation..  36:627-631. 2015
  • Guidance for infection prevention and healthcare epidemiology programs: healthcare epidemiologist skills and competencies..  36:369-380. 2015
  • The potential impact of excluding funguria from the surveillance definition of catheter-associated urinary tract infection..  36:467-469. 2015
  • A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection..  36:125-131. 2015
  • Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment..  36:34-39. 2015
  • Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals..  35:1452-1457. 2014
  • Methicillin-resistant Staphylococcus aureus bloodstream infection surveillance: National Healthcare Safety Network's laboratory-identified event reporting versus traditional laboratory-confirmed bloodstream infection surveillance..  35:1286-1289. 2014
  • A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates..  35:967-977. 2014
  • Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States..  35:978-983. 2014
  • A comparison of environmental contamination by patients infected or colonized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a multicenter study..  35:872-875. 2014
  • Strategies to prevent surgical site infections in acute care hospitals: 2014 update..  35:605-627. 2014
  • Surveying the surveillance: surgical site infections excluded by the January 2013 updated surveillance definitions..  35:570-573. 2014
  • The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research..  35:480-493. 2014
  • On contact precautions: the good, the bad, and the ugly..  35:222-224. 2014
  • Surgical antimicrobial prophylaxis: is the glass half empty or more than 99% full?.  35:240-242. 2014
  • The growing importance of non-device-associated healthcare-associated infections: a relative proportion and incidence study at an academic medical center, 2008-2012..  35:200-202. 2014
  • A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection..  35:18-27. 2014
  • Assessing the relative burden of hospital-acquired infections in a network of community hospitals..  34:1229-1230. 2013
  • Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates..  34:1055-1061. 2013
  • Comparison of non-intensive care unit (ICU) versus ICU rates of catheter-associated urinary tract infection in community hospitals..  34:744-747. 2013
  • Enterococcus species and the central line-associated bloodstream infection surveillance definition: evaluating the importance of blood culture contamination..  34:762-763. 2013
  • The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study..  34:657-662. 2013
  • Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission..  34:385-392. 2013
  • Central line-associated infections as defined by the Centers for Medicare and Medicaid Services' Hospital-acquired condition versus standard infection control surveillance: why hospital compare seems conflicted..  34:238-244. 2013
  • Observing and improving hand hygiene compliance: implementation and refinement of an electronic-assisted direct-observer hand hygiene audit program..  34:207-210. 2013
  • Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity..  34:89-92. 2013
  • Increasing rates of methicillin-resistant Staphylococcus aureus in academic hospitals: a result of active surveillance?.  34:105-106. 2013
  • Safety culture and hand hygiene: linking attitudes to behavior..  33:1280-1282. 2012
  • Casablanca redux: we are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate..  33:932-935. 2012
  • "What the eyes don't see, the heart doesn't grieve over": epidemiology and risk factors for bloodstream infections following cardiac catheterization..  33:837-841. 2012
  • Conclusion of Avery et al--validation of findings but concern about rationale..  33:856-857. 2012
  • When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae?.  33:753-756. 2012
  • Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation..  33:589-593. 2012
  • The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia..  33:558-564. 2012
  • Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapy..  33:416-420. 2012
  • The impact of depth of infection and postdischarge surveillance on rate of surgical-site infections in a network of community hospitals..  33:276-282. 2012
  • "But my patients are different!": risk adjustment in 2012 and beyond..  32:987-989. 2011
  • Seasonal and novel H1N1 influenza vaccination at a children's hospital..  32:934-936. 2011
  • Coagulase-negative staphylococcal infections in the neonatal intensive care unit..  32:679-686. 2011
  • Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients..  32:415-424. 2011
  • Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit..  32:305-314. 2011
  • Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals..  32:387-390. 2011
  • The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network..  32:315-322. 2011
  • Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?.  31:1286-1289. 2010
  • Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates..  31:1070-1073. 2010
  • Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure..  31:701-709. 2010
  • Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection..  31:357-364. 2010
  • Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery..  31:64-68. 2010
  • Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss..  30:1057-1061. 2009
  • Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection..  30:1062-1069. 2009
  • Adherence to self-quarantine recommendations during an outbreak of norovirus infection..  30:896-899. 2009
  • Emerging evidence for seasonality of gram-negative bacterial infections..  30:813-814. 2009
  • Risk factors for gram-negative bacterial surgical site infection: do allergies to antibiotics increase risk?.  30:440-446. 2009
  • Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital cost..  30:383-385. 2009
  • Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery..  30:242-248. 2009
  • Risk of sharp device-related blood and body fluid exposure in operating rooms..  29:1139-1148. 2008
  • Whither infection control in community hospitals? Musings about the near future..  29:1071-1073. 2008
  • A compendium of strategies to prevent healthcare-associated infections in acute care hospitals..  29 Suppl 1:S12-S21. 2008
  • Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting..  29:941-946. 2008
  • Strategies to prevent catheter-associated urinary tract infections in acute care hospitals..  29 Suppl 1:S41-S50. 2008
  • Strategies to prevent central line-associated bloodstream infections in acute care hospitals..  29 Suppl 1:S22-S30. 2008
  • Strategies to prevent clostridium difficile infections in acute care hospitals..  29 Suppl 1:S81-S92. 2008
  • Strategies to prevent surgical site infections in acute care hospitals..  29 Suppl 1:S51-S61. 2008
  • Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals..  29 Suppl 1:S62-S80. 2008
  • Strategies to prevent ventilator-associated pneumonia in acute care hospitals..  29 Suppl 1:S31-S40. 2008
  • Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus..  29:832-839. 2008
  • Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants?.  29:749-753. 2008